These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1742849)

  • 21. Bayesian estimation of p-aminohippurate clearance by a limited sampling strategy.
    Kinowski JM; Rodier M; Bressolle F; Fabre D; Augey V; Richard JL; Galtier M; Gomen R
    J Pharm Sci; 1995 Mar; 84(3):307-11. PubMed ID: 7616369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
    Freyer G; Tranchand B; Ligneau B; Ardiet C; Souquet PJ; Court-Fortune I; Riou R; Rebattu P; Boissel JP; Trillet-Lenoir V; Girard P
    Br J Clin Pharmacol; 2000 Oct; 50(4):315-24. PubMed ID: 11012554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer.
    Yamamoto N; Tamura T; Karato A; Uenaka K; Eguchi K; Shinkai T; Ohe Y; Oshita F; Arioka H; Nakashima H
    Jpn J Cancer Res; 1994 Sep; 85(9):972-7. PubMed ID: 7961128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of continuous infusion doxorubicin.
    Sweatman TW; Lokich JJ; Israel M
    Ther Drug Monit; 1989; 11(1):3-9. PubMed ID: 2911850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bayesian method for predicting 5-fluorouracil pharmacokinetic parameters following short-term infusion in patients with colorectal cancer.
    Climente-Martí M; Merino-Sanjuán M; Almenar-Cubells D; Jiménez-Torres NV
    J Pharm Sci; 2003 Jun; 92(6):1155-65. PubMed ID: 12761805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Bayesian dosing method for carboplatin given by continuous infusion for 120 h.
    Guillet P; Monjanel S; Nicoara A; Duffaud F; Lacarelle B; Bagarry-Liegey D; Durand A; Catalin J; Favre R
    Cancer Chemother Pharmacol; 1997; 40(2):143-9. PubMed ID: 9182836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.
    Huitema AD; Mathôt RA; Tibben MM; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Pharmacol Ther; 2000 Jun; 67(6):621-30. PubMed ID: 10872644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials.
    Nguyen L; Tranchand B; Puozzo C; Variol P
    Br J Clin Pharmacol; 2002 May; 53(5):459-68. PubMed ID: 11994051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients.
    Tranchand B; Amsellem C; Chatelut E; Freyer G; Iliadis A; Ligneau B; Trillet-Lenoir V; Canal P; Lochon I; Ardiet CJ
    Cancer Chemother Pharmacol; 1999; 43(4):316-22. PubMed ID: 10071983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies.
    Pinguet F; Culine S; Bressolle F; Astre C; Serre MP; Chevillard C; Fabbro M
    Clin Cancer Res; 2000 Jan; 6(1):57-63. PubMed ID: 10656432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide).
    van Kesteren C; Mathôt RA; Raymond E; Armand JP; Fumoleau P; Punt C; Ravic M; Wanders J; Beijnen JH; Schellens JH;
    Br J Clin Pharmacol; 2002 Nov; 54(5):463-71. PubMed ID: 12445024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disposition of doxorubicin on repeated dosing.
    Rushing DA; Piscitelli SC; Rodvold KA; Tewksbury DA
    J Clin Pharmacol; 1993 Aug; 33(8):698-702. PubMed ID: 8408728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.
    Bruno R; Rosier P; Iliadis A; Le Roux Y; Montay G; Frydman A; Gaillot J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():338-45. PubMed ID: 1820906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous adriamycin in ambulatory patients: value of an optimal planification of sampling times combined with a Bayesian evaluation of pharmacokinetic parameters].
    Launay MC; Milano G; Iliadis A; Frenay M
    Bull Cancer; 1989; 76(8):903-4. PubMed ID: 2620122
    [No Abstract]   [Full Text] [Related]  

  • 38. Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer.
    Bressolle F; Joulia JM; Pinguet F; Ychou M; Astre C; Duffour J; Gomeni R
    Cancer Chemother Pharmacol; 1999; 44(4):295-302. PubMed ID: 10447576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin pharmacokinetics following a single-dose infusion to sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; Charles BG
    Aust Vet J; 2004 Dec; 82(12):769-72. PubMed ID: 15648940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.